Last reviewed · How we verify

Lidocaine injection tourniquet

Wake Forest University Health Sciences · FDA-approved active Small molecule Quality 5/100

Lidocaine injection tourniquet is a Small molecule drug developed by Wake Forest University Health Sciences. It is currently FDA-approved. Also known as: Xylocaine, Tourniquet.

At a glance

Generic nameLidocaine injection tourniquet
Also known asXylocaine, Tourniquet
SponsorWake Forest University Health Sciences
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Lidocaine injection tourniquet

What is Lidocaine injection tourniquet?

Lidocaine injection tourniquet is a Small molecule drug developed by Wake Forest University Health Sciences.

Who makes Lidocaine injection tourniquet?

Lidocaine injection tourniquet is developed and marketed by Wake Forest University Health Sciences (see full Wake Forest University Health Sciences pipeline at /company/wake-forest-university-health-sciences).

Is Lidocaine injection tourniquet also known as anything else?

Lidocaine injection tourniquet is also known as Xylocaine, Tourniquet.

What development phase is Lidocaine injection tourniquet in?

Lidocaine injection tourniquet is FDA-approved (marketed).

Related